RT @aHUSAllianceAct: Long-term observational study of atypical HUS patients of varied ages, N=93. Notes discontinuation of #eculizumab nee…
Little info available re long-term studies on #patients w/ the #RareDisease atypical HUS. Collaboration of in'tl #aHUS expert #clinician /researchers look at N=93 re #genetics, #diagnosis, treatment, #complement, more. #DataDriven #PersonalizedMedicine h
RT aHUSAllianceAct Long-term observational study of atypical HUS patients of varied ages, N=93. Notes discontinuation of #eculizumab needs careful monitoring of #aHUS patients for organ function & risk factors for relapse, inc #genetics, age of onset,
Long-term observational study of atypical HUS patients of varied ages, N=93. Notes discontinuation of #eculizumab needs careful monitoring of #aHUS patients for organ function & risk factors for relapse, inc #genetics, age of onset, and #TMA episodes.
Menne, J.-Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in ... https://t.co/OkUmBNWdPT #OA
RT aHUSAllianceAct RT aHUSCanada: Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study (link: https://t.co/cY7t2CCKuJ) https://t.co/cY7t2CCKuJ BioMedCentral #aHUS https://t.co/WWbzIlEUDd
RT @aHUSCanada: Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study (li…
Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study (link: https://t.co/0s2tqjnI1N) https://t.co/0s2tqjnI1N @BioMedCentral #aHUS
RT aHUSAllianceAct RT ASPNeph: Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study https://t.co/cY7t2CCKuJ BioMedCentral #aHUS
RT @ASPNeph: Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study https:…
RT @ASPNeph: Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study https:…
RT @ASPNeph: Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study https:…
RT @ASPNeph: Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study https:…
Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study https://t.co/ZBSazVThPr @BioMedCentral #aHUS